Explainer: Can Quad's ‘Cancer Moonshot’ eradicate cervical cancer in the Indo-Pacific?
New Delhi: The Quad countries (United States, India, Japan, and Australia) have launched the ambitious 'Cancer Moonshot' initiative with the aim of reducing cancer mortality and improving cancer care infrastructure in the Indo-Pacific. This joint effort is starting with a focus on eliminating cervical cancer, a disease that is both preventable and treatable but still one of the leading causes of cancer deaths among women in the region. By focusing on cervical cancer, the initiative hopes to create a model for addressing other cancers across the region in the future.
Cervical cancer
Cervical cancer remains the third leading cause of cancer-related deaths among women in the Indo-Pacific, despite being largely preventable through human papillomavirus (HPV) vaccination and treatable if detected early. One of the reasons for its high mortality is the low rate of HPV vaccination and insufficient screening efforts across the region. Fewer than one in ten women in the Indo-Pacific have completed the HPV vaccination series, and only a small percentage have undergone recent screenings. This initiative aims to address these gaps and drastically reduce the burden of cervical cancer in the region.
Goals of the 'Cancer Moonshot' initiative
The Cancer Moonshot initiative focuses on strengthening the overall cancer care ecosystem in the Indo-Pacific through a combination of measures aimed at improving healthcare infrastructure, research, data collection, and cancer prevention and treatment. One of the primary goals is to enhance the health infrastructure to make cancer care more accessible, especially in underserved areas. The initiative will also promote research collaborations to encourage innovative approaches to cancer detection and treatment. Furthermore, building robust data systems will help track the effectiveness of cancer programs, while promoting efforts in prevention, screening, and treatment to provide more comprehensive care for cancer patients.
HPV vaccination and screening
To tackle cervical cancer effectively, the initiative prioritizes addressing the low HPV vaccination rates and insufficient screening coverage. The Quad countries plan to significantly boost vaccination efforts, with India playing a key role by contributing $7.5 million worth of HPV vaccines to the Indo-Pacific region. Additionally, the initiative will increase access to cervical cancer screening by working with organizations like the United Nations to lower the cost of diagnostics. Efforts will also be made to expand treatment options in underserved areas, improving overall healthcare access for those at risk.
Financial commitments from Quad countries
Quad countries are making substantial financial commitments to support the Cancer Moonshot initiative. The United States has already pledged at least $1.58 billion over five years to support the efforts of Gavi (the Vaccine Alliance), including the distribution of HPV vaccines across the Indo-Pacific. India is also sharing its expertise in digital health, offering technical assistance through its National Non-Communicable Disease (NCD) portal, which will be used to track long-term cancer data. These financial and technical commitments underscore the collaborative nature of the initiative, with each country contributing resources to improve cancer outcomes in the region.
India's contributions to the Cancer Moonshot initiative are crucial for its success. The Serum Institute of India, in partnership with Gavi, will supply up to 40 million doses of the HPV vaccine to the Indo-Pacific region. In addition to providing vaccines, India is also expanding its population-based screening for oral, breast, and cervical cancers under its National Programme for Prevention and Control of Non-Communicable Diseases (NPCDCS). India is also committed to ensuring affordable cancer treatments through the Pradhan Mantri Jan Arogya Yojana (PMJAY), a health coverage program that provides financial protection for cancer patients who need treatment.
Global support
The initiative has garnered significant support from global organizations and philanthropic entities. The Bill & Melinda Gates Foundation has announced plans to commit up to $180 million over the next four years to accelerate the global uptake of HPV vaccines and support the development of new diagnostic tools. The Global Initiative Against HPV and Cervical Cancer will work with partners in the Indo-Pacific to promote vaccination, screening, and early treatment for cervical cancer. These efforts are part of a larger global push to reduce the burden of cervical cancer, particularly in regions with limited access to healthcare.
India's contribution to the fight against cancer
India is actively expanding its cancer care infrastructure to support the goals of the Cancer Moonshot initiative. Under the "Strengthening of Tertiary Care Cancer Centres" program, India is increasing the number of specialized cancer treatment facilities across the country. The Indian Council of Medical Research (ICMR) is also conducting implementation research to improve cervical cancer screening and elimination strategies. These efforts complement India's broader commitment to enhancing cancer care and ensuring that affordable treatments are accessible to its citizens, particularly those most in need.
The Cancer Moonshot initiative is a significant step toward reducing cancer mortality in the Indo-Pacific, starting with cervical cancer. Through international collaboration, financial investments, and technological advancements, the Quad countries aim to make cancer care more accessible and effective in the region. With a focus on prevention, early detection, and affordable treatment, this initiative brings hope to millions of women and sets the stage for broader cancer care improvements in the Indo-Pacific.IANS